![Cui Ling Wu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cui Ling Wu
Président chez
Guangzhou Fulengen Co., Ltd.
Profil
Actuellement, Cui Ling Wu occupe le poste de présidente du conseil de surveillance de Guangzhou Wondfo Biotech Co., Ltd. et de présidente de Guangzhou Fulengen Co., Ltd. Elle est également membre du conseil d'administration de Da An Gene Co., Ltd. de l'université Sun Yat-Sen, directrice adjointe du Guangzhou Bio-tech Pharmaceuticals Center et professeur à l'université Sun Yat-Sen. Elle a obtenu un diplôme de premier cycle de l'université pharmaceutique de Guangdong.
Postes actifs de Cui Ling Wu
| Sociétés | Poste | Début |
|---|---|---|
Sun Yat-Sen University
 Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 09/03/2010 |
Guangzhou Bio-tech Pharmaceuticals Center | Corporate Officer/Principal | 01/03/2001 |
Guangzhou Fulengen Co., Ltd.
 Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. | Président | - |
Anciens postes connus de Cui Ling Wu
| Sociétés | Poste | Fin |
|---|---|---|
| DAAN GENE CO., LTD. | Directeur/Membre du Conseil | 27/05/2022 |
| GUANGZHOU WONDFO BIOTECH CO.,LTD | Président | - |
Formation de Cui Ling Wu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Daan Gene Co., Ltd.
 Daan Gene Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes molecular biology based reagents & medical equipment | Health Technology |
Guangzhou Bio-tech Pharmaceuticals Center | |
Guangzhou Wondfo Biotech Co., Ltd.
 Guangzhou Wondfo Biotech Co., Ltd. BiotechnologyHealth Technology Engages in the manufacture, sale of biochemical reagents, medical products and diagnostic test kits | Health Technology |
Sun Yat-Sen University
Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangdong Pharmaceutical University
 Guangdong Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangzhou Fulengen Co., Ltd.
Guangzhou Fulengen Co., Ltd. Guangzhou Fulengen Co., Ltd. is a biotechnology and life science research company specializing in genome editing tools, gene function research, and molecular biology products. The company is based in Guangzhou, China. The Chinese company develops and promotes a broad portfolio of products, including full-length cDNA and ORF expression clones, recombinant proteins, RNA interference tools (shRNA, miRNA), custom cloning services, and gene editing technologies such as CRISPR-Cas9 and TALEN. Fulengen offers genome editing solutions encompassing Cas9 proteins, sgRNA libraries, stable cell lines, validation systems, and gene knock-in kits, supporting gene editing research workflows. The company also provides miRNA research tools, qPCR reagents and arrays for gene and miRNA expression profiling, viral vector systems for gene delivery, and nucleic acid virus detection kits for pandemic-related research. Fulengen collaborates with international research institutions and biotech companies, contributing to human genome projects and developing protein expression databases. |
